Loading insider details...
Beta
Latest Form 4 (Jun 5, 2026): Exercise/Conversion of 12,840 ANIK shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 5, 2026 | Anika Therapeutics, Inc. (ANIK) | Exercise/Conversion | 12,840 | n/a |
| Apr 30, 2026 | Anika Therapeutics, Inc. (ANIK) | Purchase | 12,200 | $149.9K |
| Mar 17, 2026 | Anika Therapeutics, Inc. (ANIK) | Exercise/Conversion | 12,824 | n/a |
| Feb 3, 2026 | Anika Therapeutics, Inc. (ANIK) | Grant/Award | 310,207 | n/a |
| Jun 5, 2025 | Anika Therapeutics, Inc. (ANIK) | Exercise/Conversion | 12,840 | n/a |
| Mar 18, 2025 | Anika Therapeutics, Inc. (ANIK) | Grant/Award | 38,473 | n/a |
| Jun 5, 2024 | Anika Therapeutics, Inc. (ANIK) | Grant/Award | 38,520 | n/a |
| Apr 2, 2024 | VSE CORP (VSEC) | Grant/Award | 2,567 | n/a |
| Mar 12, 2024 | VSE CORP (VSEC) | Exercise/Conversion | 1,832 | n/a |
| Jan 2, 2024 | VSE CORP (VSEC) | Grant/Award | 233 | $11.0K |